Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177598 | SCV000229496 | benign | not specified | 2014-05-08 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000177598 | SCV000248533 | uncertain significance | not specified | 2015-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712756 | SCV000524051 | likely benign | not provided | 2020-09-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 32707200) |
Labcorp Genetics |
RCV001086675 | SCV000650402 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712756 | SCV000843280 | benign | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000712756 | SCV001155517 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BS2 |
Diagnostic Laboratory, |
RCV000712756 | SCV001744722 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000712756 | SCV001966831 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000712756 | SCV002037061 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537437 | SCV004748133 | likely benign | PLEC-related disorder | 2023-12-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |